Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
BMJ Open|June 6, 2022
Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocolFei Chen, Zoltán Novák, Christian Dannecker, et al.Journal of Cancer Research and Clinical Oncology|August 1, 2018
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancerSabine Heublein, Klaus Friese, Bernd Kost, et al.Journal of Cancer Research and Clinical Oncology|November 8, 2018
The role of EP3-receptor expression in cervical dysplasiaAnna Hester, Manuel Ritzer, Christina Kuhn, et al.Archives of Gynecology and Obstetrics|January 13, 2026
Severe fetomaternal transfusion due to an unrecognized chorangioma in a dichorionic, diamniotic twin pregnancyJonas Bubmann, Christian Dannecker, Manuela Franitza, et al.Geburtshilfe Und Frauenheilkunde|May 19, 2025
Sentinel Lymphonodectomy in Early Vulvar Cancer in Daily Practice: a Multicenter Experience from GermanyPhilipp Soergel, Matthias Hempel, Julia Gallwas, et al.International Journal of Molecular Sciences|May 14, 2022
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.Journal of Reproductive Immunology|April 20, 2023
The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patientsJohanna Mittelberger, Marina Seefried, Sanja Löb, et al.Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.Journal of Cancer Research and Clinical Oncology|July 30, 2020
Lysine-specific histone demethylase 1A (LSD1) in cervical cancerDaniel Beilner, Christina Kuhn, Bernd P Kost, et al.Journal of Cancer Research and Clinical Oncology|June 4, 2020
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)Yao Ye, Lin Peng, Aurelia Vattai, et al.Pageof 8